Services Available in the Transfusion Medicine Department of Sir Salimullah Medical College and Mitford Hospital
Kazi Mariam Naher,
Shafia Shaheen,
Baizid Khoorshid Riaz
Issue:
Volume 7, Issue 1, January 2021
Pages:
1-7
Received:
15 December 2020
Accepted:
24 December 2020
Published:
10 March 2021
Abstract: Background: Blood, is a scarce non substitute, which necessitates it for patients to have a reliable safe access to blood products at all levels. In order to identify the shortcomings in this process, this study has been designed to assess the current status of the transfusion medicine department services in one of the tertiary level hospital in Dhaka city. Subjects and Method: This cross-sectional study was conducted in the Transfusion Medicine department of Sir Salimullah Medical College and Mitford Hospital, Dhaka in 2018. The study population was a total of 275 (14 Service Providers purposively interviewed &261 blood donors taken as per convenience). Data was collected by using semi structured questionnaire, open- ended questionnaire from the Head of the Department and check list. Results: The findings revealed that all basic tests and mandatory screening tests were conducted in the unit except Bone Marrow examination and Apheresis. Important record registers (Donor care, Donor deferral register etc.) were present but not updated. Few SOPs were available but were not kept at work stations. No screening curtains were provided for donor privacy and no technicians used gloves at work. Only 1.5% donors were Voluntary. About 36% were first time donors. About 19% of donors mentioned a delay of nearly an hour for completion of donation process, though 80.5% donors were still satisfied with staff behavior. WHO criteria was followed for Donor selection in the unit. Pre and post donation counselling was extremely dissatisfying. Despite of no stocks, the unit organized mere Voluntary Blood donation activities. Conclusion: A huge number of patients rely on tertiary hospitals for blood transfusions, as it is a life-saving procedure. Voluntary blood donation can be increased by encouraging Government–NGO collaboration along with use of software for holding details of regular donors.
Abstract: Background: Blood, is a scarce non substitute, which necessitates it for patients to have a reliable safe access to blood products at all levels. In order to identify the shortcomings in this process, this study has been designed to assess the current status of the transfusion medicine department services in one of the tertiary level hospital in Dh...
Show More
Right Spontaneous Hemopneumothorax Associated with SARS-CoV-2 Infection - Case Presentation
Claudiu-Eduard Nistor,
Anca-Pati Cucu,
Camelia Stanciu-Găvan,
Adrian Ciuche
Issue:
Volume 7, Issue 1, January 2021
Pages:
8-12
Received:
31 March 2021
Accepted:
3 May 2021
Published:
14 May 2021
Abstract: Context: SARS-COV2 infection, the respiratory febrile disease firstly described in China in December 2019, which was declared a pandemic on March 11th, 2020, is associated with multiple air and fluid collections. Spontaneous hemopneumothorax in coronavirus disease 19 (COVID 19) patients is a rare clinical entity described as an unusual complication of severe COVID 19 pneumonia. Objective: The authors used the database of a single COVID 19 treatment center only. In our case series, we encountered a patient with particular hemopneumothorax features that we have decided to present. Method: A 51-year-old non-smoker male with fever and cough lasting for 7 days was admitted to the dedicated COVID 19 unit of “Dr. Carol Davila” Central University Military Hospital Bucharest. The patient developed hemopneumothorax on the 14th day since the beginning of the symptoms. The thoracic surgeon performed pleural drainage through minimal pleurotomy allowing the evacuation of both air and fluid. Results: Post interventional computed tomography scan showed the remission of hemopneumothorax. The favorable evolution and the negative SARS COV2 screening throat swab test allowed the discharge of the patient on the 25th day after initial diagnosis. Conclusions: In certain situations, COVID 19 pneumopathy may lead to hemopneumothorax with unpredictable evolution, and only a fast therapeutic intervention can save the patient’s life.
Abstract: Context: SARS-COV2 infection, the respiratory febrile disease firstly described in China in December 2019, which was declared a pandemic on March 11th, 2020, is associated with multiple air and fluid collections. Spontaneous hemopneumothorax in coronavirus disease 19 (COVID 19) patients is a rare clinical entity described as an unusual complication...
Show More
